Helius Medical regains full Nasdaq compliance; subject to one-year monitor

Solana Co

Received Nasdaq notification on July 7, 2025 confirming compliance with $2.5M stockholders' equity requirement.
Regained Minimum Bid Price compliance on June 3, 2025; now meets all continued listing criteria.
Subject to Mandatory Panel Monitor until July 7, 2026; any future equity deficiency triggers delist process.
Previous hearing panel granted continuance contingent on meeting both requirements by June 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.